This Should Triple from Here...Look at the valuations of Smart Money, not this small volume retail movements. Last January the US$20 Million Private Placements was at US$.20. Which is C$.26. Usually private placements in the biotech world expect to at least double the money for their risk. So they wouldn't bother investing that much unless worth double at C$.52. Which after price consolidation x 20 is worth $10.40. The technical analysis also shows it should hit that. It's now 99% down from peak a few years ago. This is bottom and as the trial results approach in only a few months... the hype will be back.